Evidence map›Paper›PMID 41896695›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026

MDMA alters fear extinction, and reduces alcohol consumption in inbred alcohol preferring iP rats but not outbred Wistar rats.

Kade L Huckstep, Billi Newton, Grace Bailey, Annai Charlton, Amy J Pearl, Xavier J Maddern, Robyn M Brown, Gavan P McNally, Dan I Lubman, Shalini Arunogiri and 4 more

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kade L Huckstep *Florey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.
Billi Newton *Florey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.
Grace BaileyFlorey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.
Annai CharltonFlorey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.
Amy J PearlFlorey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.
Xavier J MaddernFlorey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.
Robyn M BrownBiochemistry and Pharmacology Department, University of Melbourne, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0003-4167-3634
Gavan P McNallySchool of Psychology, University of New South Wales, Sydney, NSW, Australia.ORCID http://orcid.org/0000-0001-9061-6463
Dan I LubmanTurning Point, Eastern Health, Melbourne, VIC, Australia.
Shalini ArunogiriTurning Point, Eastern Health, Melbourne, VIC, Australia.
Kirsten C MorleySydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Erin J CampbellSchool of Biomedical Sciences and Pharmacy, College of Health and Medicine and Wellbeing, University of Newcastle, Callaghan, NSW, Australia.ORCID http://orcid.org/0000-0002-4722-6897
Andrew J LawrenceFlorey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0001-6836-727X
Leigh C WalkerFlorey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia. leigh.walker@florey.edu.au.ORCID http://orcid.org/0000-0002-9282-2743

Funding

Department of Health | National Health and Medical Research Council (NHMRC) 2002830Department of Health | National Health and Medical Research Council (NHMRC) 2008344
6 · The paper itself

Abstract

Comorbidity between post-traumatic stress disorder (PTSD) and alcohol use is common and mutually-reinforcing, yet there are no pharmacological strategies that specifically target trauma-linked escalation of alcohol intake. We evaluated whether 3,4-methylenedioxymethamphetamine (MDMA), given in a therapy-adjunctive fashion (30 min before fear extinction), could facilitate extinction of conditioned fear and reduce alcohol consumption in a rat model that combines fear conditioning, binge-like alcohol access, abstinence, and re-exposure. Inbred alcohol-preferring (iP) and outbred Wistar rats of both sexes underwent auditory fear conditioning, voluntary ethanol drinking, and subsequently fear extinction after MDMA or vehicle administration, with drug-free extinction recall and alcohol consumption assessed thereafter. Fear conditioning increased voluntary alcohol intake only in iP rats, suggesting a genotype-related fear-alcohol contingency. MDMA acutely reduced freezing during extinction, but ultimately reshaped across-session freezing patterns in a strain- and sex-dependent manner. There were no lasting MDMA treatment effects on next-day drug-free recall. MDMA also altered on-drug fear-expression during extinction without affecting later recall in an iP rat cohort without prior alcohol exposure, indicating the effect is not secondary to drinking history. Critically, MDMA prevented the shock-related increase in alcohol consumption but only in iP rats. These data suggest MDMA's most reliable action in this model is to disrupt trauma-linked escalation of alcohol intake in genetically- and experientially- vulnerable rats, rather than to globally enhance fear extinction.

Indexed as

Alcohol DrinkingExtinction, PsychologicalFearN-Methyl-3,4-methylenedioxyamphetamineAnimalsEthanolFemaleMaleRatsRats, WistarSpecies SpecificityEthanolN-Methyl-3,4-methylenedioxyamphetamine

Identifiers

PMID41896695
PMCPMC13389210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.